• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Presence of Cell-free Nucleic Acids in Blood Products

July 25, 2018

Cell-free nucleic acids (CFNAs) are often present in plasma. A new study tested whether CFNAs are also present and active in red blood cell (RBC) units, fresh frozen plasma units, and platelet concentrates. Using a nanochip bioanalyzer, double-stranded DNA fragments were found in RBC units, platelet concentrates, and fresh frozen plasma units.  Significant concentrations of RNA were not observed in any of the blood products.  Although CFNA concentrations significantly varied between the same blood component units, there was no effect of storage time on CFNA concentrations.  In addition, the study examined microarray data collected after CFNAs (from RBCS, plasma, and platelets) were cultured with macrophages. There was an increase in the expression of over 900 genes, including chemoattractant CXCL-8 (IL-8) and other genes involved in innate immunity and inflammation.  Further studies are necessary to determine if CFNAs are detectable and/or biologically active after transfusion.

Reference:

Abramowski SW, Tirefort D, Lau P, Guichebaron A, et al.  Cell-free nucleic acids are present in blood products and regulate genes of innate immune response. 

Filed Under

  • CME
  • Coagulation & Plasma Transfusion
  • News
  • Platelet Transfusion
  • RBC Transfusion

Recommended

  • RBC Transfusions for Palliative Care Patients

  • Long-term Survival of Severe Trauma Patients Treated with Tranexamic Acid

  • HLA-haploidentical Bone Marrow Transplantation May be Alternative Cure for Sickle Cell Patients

Show Comments

Reader Interactions

Comments

  1. Elvira Grandone says

    August 14, 2018 at 8:54 am

    These data can give at least in part biological plausibility to recent findings by Caraam-Deelder and coll published in JAMA in 2017, that show an increased mortality in males over 50 transfused with RBC by ever pregnant women. Fetal Free DNA is likely to persist after delivery in maternal plasma; thus we can hypothesise that multiple inflammatory triggers – driven by the mothers and one or more fetuses could lead to an increased”inflammation” and in turn to an activation of coagulation with an increased rate of mortality.

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley